Chemical Structure (Coreg 01)
Coreg Tablet, Film Coated
Product Images NDC 80725-142
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Coreg (NDC 80725-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Waylis Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Coreg 02)
Figure 2 (Coreg 03)
Figure 3 (Coreg 04)
Figure 4 (Coreg 05)
Principal Display Panel (3.125 mg Tablet Bottle Label)
Not available.*
Principal Display Panel (6.25 mg Tablet Bottle Label)
Principal Display Panel (12.5 mg Tablet Bottle Label)
Principal Display Panel (25 mg Tablet Bottle Label)
Store below 30°C (86°F). Do not accept if membrane seal under cap is missing or broken. This product comes in a light-resistant container and should be protected from moisture. Each TILTAB tablet contains 25 mg of carvedilol. Please refer to the accompanying prescribing information for dosage details. It is important to use safety closures when dispensing this product, unless otherwise directed by a physician or requested by the purchaser. This product is manufactured for Wayls Therapeutics LLC, located in Wixom, M 48383. The revision date is 0923, and the NDC number is 80725-142-20. This is a description for Whayls COREG (carvedilol) Tablets, which includes a total of 700 TILTAB tablets.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
